MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Study bolsters case that vaccines protect against long-COVID

Study bolsters case that vaccines protect against long-COVID

By

COVID-19
A scanning electron microscope image shows SARS-CoV-2 (yellow). Credit: NIAID-RML.

It may be too soon to know how often the omicron variant is associated with so-called long-COVID, but research from the Leavitt Partners’ COVID-19 Patient Recovery Alliance confirms that vaccination protects against the condition. 

Those who received at least one authorized COVID-19 vaccine dose before diagnosis were between seven and 10 times less likely to report two or more long-COVID-19 symptoms, according to the preprint study conducted before the surge of the delta variant. 

Those who received a vaccine four weeks after diagnosis were four to six times less likely to develop the condition.

Get the full story from our sister site, Drug Discovery & Development.

More recent news

About Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].